Catalent’s Bloomington plant cleared to turn out J&J’s single-dose COVID-19 vaccine: reports
Johnson & Johnson’s COVID-19 vaccine rollout has been more of a trickle than a stream so far in the U.S., with the company still on the hook to deliver some 15 million doses by next week. But J&J has said it can meet that goal, and thanks to the approval of a U.S. manufacturing site, millions… Read More »